4.8 Article

Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster

Journal

NATURE GENETICS
Volume 39, Issue 4, Pages 476-485

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng2004

Keywords

-

Funding

  1. NIAMS NIH HHS [AR-47752] Funding Source: Medline
  2. NIA NIH HHS [AG24373, AG01751, AG13154] Funding Source: Medline
  3. NIDDK NIH HHS [DK73691] Funding Source: Medline
  4. NIEHS NIH HHS [U54 ES015678] Funding Source: Medline
  5. NINDS NIH HHS [NS41850, NS21328] Funding Source: Medline

Ask authors/readers for more resources

We investigated the pathophysiology of neurofibromatosis-1 (NF1) in Drosophila melanogaster by inactivation or overexpression of the NF1 gene. NF1 gene mutants had shortened life spans and increased vulnerability to heat and oxidative stress in association with reduced mitochondrial respiration and elevated reactive oxygen species (ROS) production. Flies overexpressing NF1 had increased life spans, improved reproductive fitness, increased resistance to oxidative and heat stress in association with increased mitochondrial respiration and a 60% reduction in ROS production. These phenotypic effects proved to be modulated by the adenylyl cyclase/cyclic AMP (cAMP)/protein kinase A pathway, not the Ras/Raf pathway. Treatment of wild-type D. melanogaster with cAMP analogs increased their life span, and treatment of NF1 mutants with metalloporphyrin catalytic antioxidant compounds restored their life span. Thus, neurofibromin regulates longevity and stress resistance through cAMP regulation of mitochondrial respiration and ROS production, and NF1 may be treatable using catalytic antioxidants.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available